Role of tyrosine kinase and PKC in the vasoconstrictor response to 20- HETE in renal arterioles

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 414-418

  Sun, Cheng Wen ^b   Falck, John R ^b   Harder, David R ^b   Roman, Richard J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

Arachidonic acid; Cytochrome P450; Kinase; Muscle, smooth, vascular; Potassium channels; Renal circulation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; GENISTEIN; HYDROXYICOSATETRAENOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; KIDNEY BLOOD FLOW; KIDNEY PROXIMAL TUBULE; MICROCIRCULATION; NONHUMAN; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 0032946311     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.414     Document Type: Article

References (23)

1. Ma Y-H, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE, Masters BS, Harder DR, Roman RJ. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res. 1993; 72:126-136.
2. + channel in renal arterioles. Am J Physiol. 1996;270: R226-R237.
3. Imig JD, Zou AP, Stec DE, Harder DR, Falck JR, Roman RJ. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol. 1996;270:R217-R227.
4. Zou AP, Imig JD, Kaldunski MI, Ortiz de Montellano PR, Sui Z, Roman RJ. Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am J Physiol. 1994;266:F275-F282.
5. + channel activity and vascular tone in renal arterioles. Circ Res. 1998;83:1069-1079.
6. Endo Y, Arima S, Yaoita H, Omata K, Ito S. Diverse contribution of cytochrome P450-dependent metabolite of arachidonic acid to the action of angiotensin II in isolated and microperfused rabbit afferent arterioles. Hypertension. 1998;32(part II):622. Abstract.
7. Lange A, Gebremedhin D, Narayanan J, Harder D. 20-Hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C. J Biol Chem. 1997;272:27345-27352.
8. +-ATPase. J Clin Invest. 1997;99:1224-1230.
9. Lin F, Rios A, Falck JR, Belosludtsev Y, Schwartzman ML. 20-Hydroxyeicosatetraenoic acid is formed in response to EGF and is a mitogen in rat proximal tubule. Am J Physiol. 1995;269:F806-F816.
10. Uddin MR, Muthalif MM, Karzoun NA, Benter IF, Malik KU. Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling. Hypertension. 1998;31:242-247.
11. Berk BC, Alexander RW, Brock TA, Gimbrone MA, Webb RC. Vasoconstriction: a new activity for platelet-derived growth factor. Science 1986;232:87-90.
12. Berk BC, Brock TA, Webb RC, Taubman MB, Atkinson WJ, Gimbrone MA, Alexander RW. Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction. J Clin Invest 1985;75: 1083-1086.
13. + channels. Cell. 1990;61:769-776.
14. D'Angelo G, Meininger GA. Transduction mechanisms involved in the regulation of myogenic activity. Hypertension. 1994;23:1096-1105.
15. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S. Oncogenes and signal transduction. Cell. 1991;64:281-302.
16. + channel activity by tyrosine kinase inhibitors in vascular smooth muscle cells. Eur J Pharmacol. 1995;290:117-123.
17. Di Salvo J, Steusloff A, Semenchuk L, Satoh S, Kolquist K, Pfitzer G. Tyrosine kinase inhibitors suppress agonist induced contraction in smooth muscle. Biochem Biophys Res Commun. 1993;190:968-974.
18. Saifeddine MA, Laniyony A, Yang S-G, Hollenberg MD. Tyrosine kinase inhibitors and the contractile action of angiotensin II in vascular tissue. Pharmacol Res Commun. 1992;1:177-184.
19. Watts SW, Yeum CH, Campbell G, Webb RC. Serotonin stimulates protein tyrosyl phosphorylation and vascular constriction via tyrosine kinase. J Vasc Res. 1996;33:288-298.
20. Abebe W, Agrawal DK. Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle. J Cardiovasc Pharmacol. 1995;26:153-159.
21. Golubic M, Tanaka K, Dobrowolski S, Wood D, Tsai MH, Marshall M. The GTPase stimulatory activities of the neurofibromatosis type 1 and the yeast 1RA2 proteins are inhibited by arachidonic acid. EMBO J. 1991; 10:2897-2903.
22. Yu C-L, Tsai MH, Stacey DW. Serum stimulation of NIH 3T3 cells induces the production of lipids able to inhibit GTPase-activating protein activity. Mol Cell Biol. 1990;10:6683-6689.
23. + channel. Am J Physiol. 1998;274:C138-C148.